DURHAM, NC — EpiCypher®, a leader in chromatin biology and epigenetics, today announced the launch of its CUTANA® Fiber-seq Kit and the exclusive licensing of key Fiber-seq technology from the Altius Institute for Biomedical Sciences. This milestone marks a major step toward making advanced chromatin fiber mapping technology accessible to researchers around the world. Fiber-seq, developed at […]

BOSTON and SAN DIEGO — SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific discovery, today announced at the Association for Molecular Pathology (AMP) Annual Meeting a partnership that unites sequencing and AI analytics to streamline genomic workflows and accelerate the research supporting […]

Company initiates search for successor ROCKVILLE, Md. — MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that Chief Financial Officer Douglas Swirsky has informed the Company of his decision to transition from his role in the first […]

BOSTON — Volta Labs, a leader in NGS automation, today announced a major expansion of its Callisto™ Sample Preparation Platform. Callisto now delivers fully automated DNA library preparation for any sequencer and any chemistry used in whole-genome sequencing (WGS), bringing seven validated WGS DNA Apps to Callisto. With workflows spanning Illumina, Oxford Nanopore Technologies (ONT), PacBio, Element Biosciences, […]

Landmark dataset aims to transform understanding of immune-driven illness and accelerate drug discovery SAN FRANCISCO & SEATTLE — Third Rock Ventures and Parse Biosciences today announced a strategic collaboration to create an unprecedented atlas of 5 million T cell receptors (TCRs) using Parse Biosciences’ GigaLab platform. The project is led by a stealth Third Rock […]

BOSTON — Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM™ on Complete Genomics’ DNBSEQ-T1+ sequencing platform. The companies aim to broaden access to precision oncology testing by offering the best-in-class liquid biopsy […]

Schlieren, Switzerland — InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed the definitive agreement to acquire DOPPL SA, a Lausanne-based innovator in the organoid space, including the Sun Bioscience Gri3D® technology. The acquisition strengthens InSphero’s position as the most comprehensive provider of advanced 3D in vitro models, combining scalable spheroid and organoid technologies with integrated assay […]

Oxford Nanopore Technologies today announced that Rosemary Sinclair Dokos has been appointed as Chief Product and Marketing Officer and Dr Lakmal Jayasinghe has been appointed as Chief Scientific Officer, effective immediately. Rosemary and Lakmal succeed Clive Brown, Chief Officer of Technology, Innovation, and Products, who has stepped down to pursue new projects. Clive will be […]

Framingham, MA – Ensorcell, the newest company to emerge from Re:Build Manufacturing, has officially launched operations in Framingham, Massachusetts. Ensorcell evaluates critical research and bioprocess technologies to develop innovative, intuitive and cost-effective solutions. Research, development and manufacturing are all United States-based, drawing from the vast network of cross-sector engineering and operations expertise in the Re:Build Manufacturing ecosystem. “At Re:Build […]

CAPE TOWN, South Africa — MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced two historic milestones in African genomics: the official unveiling of the continent’s first DNBSEQ-T7 sequencing platform at the South African Medical Research Council (SAMRC), and the signing of a Memorandum […]